145 related articles for article (PubMed ID: 2240158)
1. Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease.
Eigenbrodt ML; Eigenbrodt EH; Thiele DL
Am J Pathol; 1990 Nov; 137(5):1065-76. PubMed ID: 2240158
[TBL] [Abstract][Full Text] [Related]
2. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease.
Brown GR; Lindberg G; Meddings J; Silva M; Beutler B; Thiele D
Gastroenterology; 1999 Mar; 116(3):593-601. PubMed ID: 10029618
[TBL] [Abstract][Full Text] [Related]
4. Chronic mucosal changes of the colon in graft-versus-host disease.
Asplund S; Gramlich TL
Mod Pathol; 1998 Jun; 11(6):513-5. PubMed ID: 9647587
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
Mermet I; Kleinclauss F; Marandin A; Guérrini JS; Angonin R; Tiberghien P; Saas P; Aubin F
Transplantation; 2007 Dec; 84(12):1696-700. PubMed ID: 18165783
[TBL] [Abstract][Full Text] [Related]
6. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
Ellison CA; Fischer JM; HayGlass KT; Gartner JG
J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
[TBL] [Abstract][Full Text] [Related]
7. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
8. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
9. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
Fast LD
J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
[TBL] [Abstract][Full Text] [Related]
10. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
[TBL] [Abstract][Full Text] [Related]
12. The murine forestomach: a sensitive site for graft-versus-host disease.
Sale GE; Farr A; Hamilton BL
Bone Marrow Transplant; 1991 Apr; 7(4):263-7. PubMed ID: 2070131
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
14. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
15. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
17. Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.
Charley MR; Mikhael A; Bennett M; Gilliam JN; Sontheimer RD
J Immunol; 1983 Nov; 131(5):2101-3. PubMed ID: 6355291
[TBL] [Abstract][Full Text] [Related]
18. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.
Zhao D; Kim YH; Jeong S; Greenson JK; Chaudhry MS; Hoepting M; Anderson ER; van den Brink MR; Peled JU; Gomes AL; Slingerland AE; Donovan MJ; Harris AC; Levine JE; Ozbek U; Hooper LV; Stappenbeck TS; Ver Heul A; Liu TC; Reddy P; Ferrara JL
J Clin Invest; 2018 Nov; 128(11):4970-4979. PubMed ID: 30106382
[TBL] [Abstract][Full Text] [Related]
19. Recipient mucosal-associated invariant T cells control GVHD within the colon.
Varelias A; Bunting MD; Ormerod KL; Koyama M; Olver SD; Straube J; Kuns RD; Robb RJ; Henden AS; Cooper L; Lachner N; Gartlan KH; Lantz O; Kjer-Nielsen L; Mak JY; Fairlie DP; Clouston AD; McCluskey J; Rossjohn J; Lane SW; Hugenholtz P; Hill GR
J Clin Invest; 2018 May; 128(5):1919-1936. PubMed ID: 29629900
[TBL] [Abstract][Full Text] [Related]
20. Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation.
Bryson JS; Jennings CD; Caywood BE; Dix AR; Lowery DM; Kaplan AM
Bone Marrow Transplant; 1997 Apr; 19(7):721-8. PubMed ID: 9156250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
